R. Roubenoff et al., Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus, AIDS, 13(2), 1999, pp. 231-239
Background: To assess the efficacy of progressive resistance training (PRT)
in increasing strength and lean body mass (LBM) in HIV-infected adults.
Methods: Twenty-five adults with HIV infection were trained using a highly
intensive PRT regimen for 8 weeks, followed by an additional 8 weeks of obs
ervation under ad libitum physical activity conditions.
Results: Twenty-four of the 25 patients completed the first phase of the st
udy. They had significant increases in strength on all four exercises teste
d (P < 0.0001), and an increase in LBM of 1.75 +/- 1.94 kg (mean +/- SD, P
< 0.0002), with a concomitant decline in fat of 0.92 +/- 2.22 kg (P < 0.05)
, and no significant change in weight or bone mineral content. Twenty-one o
f the patients returned for follow-up 8 weeks after completing the PRT. Com
pared with their baseline values, their mean lean mass remained 1.40 +/- 1.
8 kg higher (P < 0.003). Among those who continued to train to some extent,
lean mass increased by a mean of 1.1 +/- 1.6 kg (n = 9, P < 0.05 versus en
d of PRT), whereas those who did no further training showed an increase in
lean mass of 0.28 +/- 1.4 kg (n = 12, P = NS versus end of PRT). The differ
ence between the two groups was not, however, significant (P = 0.25). Among
six patients with AIDS wasting, the increase in LBM was larger than among
non-wasted patients (2.8 versus 1.4 kg, P < 0.06), and there was an increas
e in both weight (+3.9 versus -0.2 kg, P < 0.002) and fat mass (+ 0.95 vers
us -1.5 kg, P < 0.002) at 8 weeks, which persisted at 16 weeks (weight: +4.
0 versus -1.6 kg, P < 0.0002; fat: +1.6 versus -1.9 kg, P < 0.01).
Conclusion: This preliminary study suggests that short-term, high intensity
PRT can significantly increase LBM and strength in HIV infection, and may
be used as an alternative or adjunct to pharmacological anabolic treatments
in this disease. (C) 1999 Lippincott Williams & Wilkins.